KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Accumulated Expenses (2016 - 2025)

Exact Sciences (EXAS) has disclosed Accumulated Expenses for 16 consecutive years, with $416.5 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses rose 26.86% to $416.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $416.5 million through Dec 2025, up 26.86% year-over-year, with the annual reading at $416.5 million for FY2025, 26.86% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $416.5 million at Exact Sciences, up from $408.8 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $416.5 million in Q4 2025, with the low at $214.1 million in Q1 2021.
  • Average Accumulated Expenses over 5 years is $315.3 million, with a median of $308.1 million recorded in 2022.
  • The sharpest move saw Accumulated Expenses soared 90.67% in 2021, then crashed 33.91% in 2023.
  • Over 5 years, Accumulated Expenses stood at $398.6 million in 2021, then decreased by 24.92% to $299.2 million in 2022, then grew by 14.19% to $341.7 million in 2023, then fell by 3.92% to $328.3 million in 2024, then increased by 26.86% to $416.5 million in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods came in at $416.5 million, $408.8 million, and $317.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.